Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-382475

Chief Development Officer acquired 328 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Grant or award : show line 1 in the form +164 $113.38 $18,594 4,149 D
2026-09-01 Grant or award : show line 2 in the form +164 4,313 D
Loading xslF345X06/ownership.xml…